To identify strong performers, ETMarkets analyzed stocks with a profit margin of at least 10% in each of the last three quarters (June 2024 to December 2025).
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.